Cel-Sci Corp., a Maryland and Virginia-based biotechnology company, yesterday was awarded a $50,000 state grant to help the company continue work on a new test for HIV, the AIDS virus.
The grant was made under the Maryland Industrial Partnerships, or MIPS, program, which supports the development of new technologies that could benefit Maryland's economy.
The award requires publicly held Cel-Sci, which has its research facility in Baltimore and its executive offices in Alexandria, Va., to match the grant.
Dr. Niel Constantine, a University of Maryland researcher, also is a recipient of the grant. He is working with Cel-Sci to develop the new test, which is called an enzyme-linked immunosorbent assay, or ELISA test, to detect HIV antibodies in the body.
Geert Kersten, Cel-Sci's chief executive officer, said the test is meant to provide an inexpensive way to track the progression of the virus and the human immune system's response to treatments for it.
The company hopes to have the test fully developed by next summer, Kersten said.
Pub Date: 7/09/96